Non-toxic polymer nanovectors for improved delivery of dexamethasone
Abstract Dexamethasone (Dex) is a highly insoluble front-line drug used in cancer therapy. Data from clinical trials indicates that the pharmacokinetics of Dex vary considerably between patients and prolonging drug exposure rather than increasing absolute dose may improve efficacy. Non-toxic, fully...
Guardado en:
Autores principales: | Benjamin C. Ede, Paraskevi Diamanti, David S. Williams, Allison Blair |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b565fee84e34ae2a46e1d888530d47a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications
por: Rondon EP, et al.
Publicado: (2020) -
Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments
por: Stephen J. Winter, et al.
Publicado: (2021) -
Gene transfer using micellar nanovectors inhibits choroidal neovascularization in vivo.
por: Aya Iriyama, et al.
Publicado: (2011) -
Hyaluronic acid-coated bovine serum albumin nanoparticles loaded with brucine as selective nanovectors for intra-articular injection
por: Chen Z, et al.
Publicado: (2013) -
Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair
por: Zhu K, et al.
Publicado: (2014)